Login / Signup

Impact on glycated haemoglobin and body weight changes after stopping tirzepatide for 4 weeks in the SURPASS-1 monotherapy trial.

Julio RosenstockClare J LeeLaura Fernández LandóMinzhi LiuChrisanthi A KaranikasVivian T Thieu
Published in: Diabetes, obesity & metabolism (2023)
Keyphrases
  • body weight
  • phase iii
  • study protocol
  • open label
  • clinical trial
  • phase ii
  • combination therapy
  • randomized controlled trial
  • gestational age